Compare BSRR & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSRR | PACB |
|---|---|---|
| Founded | 1977 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.7M | 521.8M |
| IPO Year | 2001 | 2010 |
| Metric | BSRR | PACB |
|---|---|---|
| Price | $42.91 | $1.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $37.00 | $1.67 |
| AVG Volume (30 Days) | 61.1K | ★ 5.9M |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.93% | N/A |
| EPS Growth | ★ 10.28 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $11.74 | $11.32 |
| Revenue Next Year | $3.63 | $12.14 |
| P/E Ratio | $44.77 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $26.49 | $1.09 |
| 52 Week High | $43.13 | $2.73 |
| Indicator | BSRR | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 69.78 | 47.40 |
| Support Level | $35.43 | $1.29 |
| Resistance Level | N/A | $1.79 |
| Average True Range (ATR) | 1.09 | 0.12 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 93.39 | 6.49 |
Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.